Your browser doesn't support javascript.
loading
Integrin ß1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110ß signaling.
Yang, Dejun; Tang, Yuan; Fu, Hongbing; Xu, Jiapeng; Hu, Zunqi; Zhang, Yu; Cai, Qingping.
Afiliação
  • Yang D; Department of Gastrointestinal Surgery, Changzheng Hospital, Second Military Medical University, China.
  • Tang Y; Department of Gastrointestinal Surgery, Changzheng Hospital, Second Military Medical University, China.
  • Fu H; Department of Gastrointestinal Surgery, Changzheng Hospital, Second Military Medical University, China.
  • Xu J; Department of Gastrointestinal Surgery, Changzheng Hospital, Second Military Medical University, China.
  • Hu Z; Department of Gastrointestinal Surgery, Changzheng Hospital, Second Military Medical University, China.
  • Zhang Y; Department of Gastrointestinal Surgery, Changzheng Hospital, Second Military Medical University, China.
  • Cai Q; Department of Gastrointestinal Surgery, Changzheng Hospital, Second Military Medical University, China. Electronic address: caiqingping@smmu.edu.cn.
Biochem Biophys Res Commun ; 505(1): 215-221, 2018 10 20.
Article em En | MEDLINE | ID: mdl-30243721

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Resistencia a Medicamentos Antineoplásicos / Integrina beta1 / Proteína cdc42 de Ligação ao GTP / Desoxicitidina / Classe Ia de Fosfatidilinositol 3-Quinase Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Resistencia a Medicamentos Antineoplásicos / Integrina beta1 / Proteína cdc42 de Ligação ao GTP / Desoxicitidina / Classe Ia de Fosfatidilinositol 3-Quinase Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article